Close Menu

NEW YORK (GenomeWeb) – Trovagene today announced it has signed an agreement to provide its Precision Cancer Monitoring tests and services to the national preferred provider organization FedMed.

Under the terms of the agreement, Trovagene will be covered as a participating laboratory testing provider for FedMed clients, which include major health insurers such as Aetna, Cigna and Humana. FedMed's network includes over 550,000 in-network physicians nationwide, the firm said in a statement.

Financial details of the agreement weren't disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Jun
02
Sponsored by
NanoString

Core facilities support a broad range of scientific studies and must constantly integrate new technologies and analysis to underpin their users’ research. Areas for development include higher multiplex capabilities, greater quantification, correlation to other tools, as well as multi-omics. 

Jun
04
Sponsored by
Ovation

This webinar will discuss the current status of COVID-19 testing, treatment and other aspects of the current pandemic as they relate to getting this outbreak under control.